Zarontin TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: ethosuximide
Brand name
(ARTG)
: ZARONTIN ethosuximide 250mg capsule bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ZARONTIN is indicated for the control of petit mal epilepsy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, soft
- Oral
- Clear medium orange capsules printed P-D 237.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 100 capsules pack
- 200 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ethosuximide
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
